Physiological	B:C1372798
Impact	I:C1372798
of	O
Platelet	O
Apheresis	I:C0032202
in	O
Pigs	O
:	O
Oxygen	O
Metabolism	I:C3156653
and	O
Coagulation	O
.	O

Physiological	O
Impact	I:C1372798
of	O
Platelet	B:C0032202
Apheresis	I:C0032202
in	O
Pigs	O
:	O
Oxygen	O
Metabolism	I:C3156653
and	O
Coagulation	O
.	O

Physiological	O
Impact	I:C1372798
of	O
Platelet	O
Apheresis	I:C0032202
in	O
Pigs	B:C0039005
:	O
Oxygen	O
Metabolism	I:C3156653
and	O
Coagulation	O
.	O

Physiological	O
Impact	I:C1372798
of	O
Platelet	O
Apheresis	I:C0032202
in	O
Pigs	O
:	O
Oxygen	B:C3156653
Metabolism	I:C3156653
and	O
Coagulation	O
.	O

Physiological	O
Impact	I:C1372798
of	O
Platelet	O
Apheresis	I:C0032202
in	O
Pigs	O
:	O
Oxygen	O
Metabolism	I:C3156653
and	O
Coagulation	B:C0005778
.	O

Platelet	B:C0032202
apheresis	I:C0032202
is	O
a	O
routine	O
clinical	I:C1516623
practice	I:C1516623
,	O
but	O
the	O
physiological	O
impact	I:C1372798
on	O
the	O
donors	O
has	O
been	O
incompletely	O
characterized	O
.	O

Platelet	O
apheresis	I:C0032202
is	O
a	O
routine	B:C1516623
clinical	I:C1516623
practice	I:C1516623
,	O
but	O
the	O
physiological	O
impact	I:C1372798
on	O
the	O
donors	O
has	O
been	O
incompletely	O
characterized	O
.	O

Platelet	O
apheresis	I:C0032202
is	O
a	O
routine	O
clinical	I:C1516623
practice	I:C1516623
,	O
but	O
the	O
physiological	B:C1372798
impact	I:C1372798
on	O
the	O
donors	O
has	O
been	O
incompletely	O
characterized	O
.	O

Platelet	O
apheresis	I:C0032202
is	O
a	O
routine	O
clinical	I:C1516623
practice	I:C1516623
,	O
but	O
the	O
physiological	O
impact	I:C1372798
on	O
the	O
donors	B:C0013018
has	O
been	O
incompletely	O
characterized	O
.	O

This	O
study	B:C0008972
measured	O
the	O
effects	O
of	O
platelet	O
apheresis	I:C0032202
on	O
hemodynamics	O
,	O
oxygen	O
metabolism	I:C3156653
,	O
and	O
coagulation	O
in	O
pigs	O
to	O
assess	O
its	O
impact	O
before	O
employing	O
the	O
animals	O
in	O
experimental	O
studies	I:C0681814
.	O

This	O
study	O
measured	O
the	O
effects	O
of	O
platelet	B:C0032202
apheresis	I:C0032202
on	O
hemodynamics	O
,	O
oxygen	O
metabolism	I:C3156653
,	O
and	O
coagulation	O
in	O
pigs	O
to	O
assess	O
its	O
impact	O
before	O
employing	O
the	O
animals	O
in	O
experimental	O
studies	I:C0681814
.	O

This	O
study	O
measured	O
the	O
effects	O
of	O
platelet	O
apheresis	I:C0032202
on	O
hemodynamics	B:C0019010
,	O
oxygen	O
metabolism	I:C3156653
,	O
and	O
coagulation	O
in	O
pigs	O
to	O
assess	O
its	O
impact	O
before	O
employing	O
the	O
animals	O
in	O
experimental	O
studies	I:C0681814
.	O

This	O
study	O
measured	O
the	O
effects	O
of	O
platelet	O
apheresis	I:C0032202
on	O
hemodynamics	O
,	O
oxygen	B:C3156653
metabolism	I:C3156653
,	O
and	O
coagulation	O
in	O
pigs	O
to	O
assess	O
its	O
impact	O
before	O
employing	O
the	O
animals	O
in	O
experimental	O
studies	I:C0681814
.	O

This	O
study	O
measured	O
the	O
effects	O
of	O
platelet	O
apheresis	I:C0032202
on	O
hemodynamics	O
,	O
oxygen	O
metabolism	I:C3156653
,	O
and	O
coagulation	B:C0005778
in	O
pigs	O
to	O
assess	O
its	O
impact	O
before	O
employing	O
the	O
animals	O
in	O
experimental	O
studies	I:C0681814
.	O

This	O
study	O
measured	O
the	O
effects	O
of	O
platelet	O
apheresis	I:C0032202
on	O
hemodynamics	O
,	O
oxygen	O
metabolism	I:C3156653
,	O
and	O
coagulation	O
in	O
pigs	B:C0039005
to	O
assess	O
its	O
impact	O
before	O
employing	O
the	O
animals	O
in	O
experimental	O
studies	I:C0681814
.	O

This	O
study	O
measured	O
the	O
effects	O
of	O
platelet	O
apheresis	I:C0032202
on	O
hemodynamics	O
,	O
oxygen	O
metabolism	I:C3156653
,	O
and	O
coagulation	O
in	O
pigs	O
to	O
assess	O
its	O
impact	O
before	O
employing	O
the	O
animals	B:C0003062
in	O
experimental	O
studies	I:C0681814
.	O

This	O
study	O
measured	O
the	O
effects	O
of	O
platelet	O
apheresis	I:C0032202
on	O
hemodynamics	O
,	O
oxygen	O
metabolism	I:C3156653
,	O
and	O
coagulation	O
in	O
pigs	O
to	O
assess	O
its	O
impact	O
before	O
employing	O
the	O
animals	O
in	O
experimental	B:C0681814
studies	I:C0681814
.	O

Forty	O
pigs	B:C0039005
(	O
39.8	O
±	O
0.6	O
kg	O
)	O
were	O
anesthetized	O
and	O
catheterized	O
with	O
an	O
apheresis	O
catheter	O
in	O
the	O
femoral	O
vein	I:C0015809
.	O

Forty	O
pigs	O
(	O
39.8	O
±	O
0.6	O
kg	O
)	O
were	O
anesthetized	B:C0002903
and	O
catheterized	O
with	O
an	O
apheresis	O
catheter	O
in	O
the	O
femoral	O
vein	I:C0015809
.	O

Forty	O
pigs	O
(	O
39.8	O
±	O
0.6	O
kg	O
)	O
were	O
anesthetized	O
and	O
catheterized	B:C0007430
with	O
an	O
apheresis	O
catheter	O
in	O
the	O
femoral	O
vein	I:C0015809
.	O

Forty	O
pigs	O
(	O
39.8	O
±	O
0.6	O
kg	O
)	O
were	O
anesthetized	O
and	O
catheterized	O
with	O
an	O
apheresis	B:C0005791
catheter	O
in	O
the	O
femoral	O
vein	I:C0015809
.	O

Forty	O
pigs	O
(	O
39.8	O
±	O
0.6	O
kg	O
)	O
were	O
anesthetized	O
and	O
catheterized	O
with	O
an	O
apheresis	O
catheter	B:C0085590
in	O
the	O
femoral	O
vein	I:C0015809
.	O

Forty	O
pigs	O
(	O
39.8	O
±	O
0.6	O
kg	O
)	O
were	O
anesthetized	O
and	O
catheterized	O
with	O
an	O
apheresis	O
catheter	O
in	O
the	O
femoral	B:C0015809
vein	I:C0015809
.	O

During	O
the	O
platelet	B:C0032202
apheresis	I:C0032202
process	O
,	O
blood	O
was	I:C0005834
withdrawn	I:C0005834
from	O
the	O
pig	O
to	O
separate	O
platelets	O
,	O
and	O
the	O
remaining	O
red	O
blood	I:C0014792
cells	I:C0014792
and	O
plasma	O
returned	O
back	O
to	O
the	O
pigs	O
,	O
using	O
the	O
Haemonetics	O
MCS+9000	O
system	O
.	O

During	O
the	O
platelet	O
apheresis	I:C0032202
process	O
,	O
blood	B:C0005834
was	I:C0005834
withdrawn	I:C0005834
from	O
the	O
pig	O
to	O
separate	O
platelets	O
,	O
and	O
the	O
remaining	O
red	O
blood	I:C0014792
cells	I:C0014792
and	O
plasma	O
returned	O
back	O
to	O
the	O
pigs	O
,	O
using	O
the	O
Haemonetics	O
MCS+9000	O
system	O
.	O

During	O
the	O
platelet	O
apheresis	I:C0032202
process	O
,	O
blood	O
was	I:C0005834
withdrawn	I:C0005834
from	O
the	O
pig	B:C0039005
to	O
separate	O
platelets	O
,	O
and	O
the	O
remaining	O
red	O
blood	I:C0014792
cells	I:C0014792
and	O
plasma	O
returned	O
back	O
to	O
the	O
pigs	O
,	O
using	O
the	O
Haemonetics	O
MCS+9000	O
system	O
.	O

During	O
the	O
platelet	O
apheresis	I:C0032202
process	O
,	O
blood	O
was	I:C0005834
withdrawn	I:C0005834
from	O
the	O
pig	O
to	O
separate	B:C0007616
platelets	O
,	O
and	O
the	O
remaining	O
red	O
blood	I:C0014792
cells	I:C0014792
and	O
plasma	O
returned	O
back	O
to	O
the	O
pigs	O
,	O
using	O
the	O
Haemonetics	O
MCS+9000	O
system	O
.	O

During	O
the	O
platelet	O
apheresis	I:C0032202
process	O
,	O
blood	O
was	I:C0005834
withdrawn	I:C0005834
from	O
the	O
pig	O
to	O
separate	O
platelets	B:C0005821
,	O
and	O
the	O
remaining	O
red	O
blood	I:C0014792
cells	I:C0014792
and	O
plasma	O
returned	O
back	O
to	O
the	O
pigs	O
,	O
using	O
the	O
Haemonetics	O
MCS+9000	O
system	O
.	O

During	O
the	O
platelet	O
apheresis	I:C0032202
process	O
,	O
blood	O
was	I:C0005834
withdrawn	I:C0005834
from	O
the	O
pig	O
to	O
separate	O
platelets	O
,	O
and	O
the	O
remaining	O
red	B:C0014792
blood	I:C0014792
cells	I:C0014792
and	O
plasma	O
returned	O
back	O
to	O
the	O
pigs	O
,	O
using	O
the	O
Haemonetics	O
MCS+9000	O
system	O
.	O

During	O
the	O
platelet	O
apheresis	I:C0032202
process	O
,	O
blood	O
was	I:C0005834
withdrawn	I:C0005834
from	O
the	O
pig	O
to	O
separate	O
platelets	O
,	O
and	O
the	O
remaining	O
red	O
blood	I:C0014792
cells	I:C0014792
and	O
plasma	B:C0032105
returned	O
back	O
to	O
the	O
pigs	O
,	O
using	O
the	O
Haemonetics	O
MCS+9000	O
system	O
.	O

During	O
the	O
platelet	O
apheresis	I:C0032202
process	O
,	O
blood	O
was	I:C0005834
withdrawn	I:C0005834
from	O
the	O
pig	O
to	O
separate	O
platelets	O
,	O
and	O
the	O
remaining	O
red	O
blood	I:C0014792
cells	I:C0014792
and	O
plasma	O
returned	O
back	O
to	O
the	O
pigs	B:C0039005
,	O
using	O
the	O
Haemonetics	O
MCS+9000	O
system	O
.	O

A	O
total	O
of	O
12	O
cycles	O
of	O
blood	O
withdrawn	O
and	O
return	O
were	O
performed	O
during	O
the	O
entire	O
apheresis	B:C0005791
procedure	I:C0005791
to	O
reduce	O
platelet	O
counts	I:C0032181
to	O
a	O
target	O
of	O
50	O
%	O
of	O
baseline	O
.	O

A	O
total	O
of	O
12	O
cycles	O
of	O
blood	O
withdrawn	O
and	O
return	O
were	O
performed	O
during	O
the	O
entire	O
apheresis	O
procedure	I:C0005791
to	O
reduce	O
platelet	B:C0032181
counts	I:C0032181
to	O
a	O
target	O
of	O
50	O
%	O
of	O
baseline	O
.	O

During	O
the	O
process	O
,	O
hemodynamics	B:C0019010
was	O
recorded	O
in	O
each	O
cycle	O
.	O

Blood	B:C0178913
samples	I:C0178913
were	O
collected	O
before	O
and	O
after	O
apheresis	O
to	O
assess	O
changes	O
in	O
oxygen	O
metabolism	I:C3156653
and	O
coagulation	O
by	O
prothrombin	O
time	I:C0033707
,	O
activated	O
partial	I:C0030605
thromboplastin	I:C0030605
time	I:C0030605
(	O
STA	O
-	O
R	O
Evolution	O
Stago	O
)	O
,	O
and	O
using	O
Rotem	O
thrombelastometry	I:C0040017
,	O
and	O
platelet	O
aggregation	I:C0032176
using	O
a	O
Chrono	O
-	O
Log	O
700	O
aggregometer	O
.	O

Blood	O
samples	I:C0178913
were	O
collected	O
before	O
and	O
after	O
apheresis	B:C0005791
to	O
assess	O
changes	O
in	O
oxygen	O
metabolism	I:C3156653
and	O
coagulation	O
by	O
prothrombin	O
time	I:C0033707
,	O
activated	O
partial	I:C0030605
thromboplastin	I:C0030605
time	I:C0030605
(	O
STA	O
-	O
R	O
Evolution	O
Stago	O
)	O
,	O
and	O
using	O
Rotem	O
thrombelastometry	I:C0040017
,	O
and	O
platelet	O
aggregation	I:C0032176
using	O
a	O
Chrono	O
-	O
Log	O
700	O
aggregometer	O
.	O

Blood	O
samples	I:C0178913
were	O
collected	O
before	O
and	O
after	O
apheresis	O
to	O
assess	O
changes	O
in	O
oxygen	B:C3156653
metabolism	I:C3156653
and	O
coagulation	O
by	O
prothrombin	O
time	I:C0033707
,	O
activated	O
partial	I:C0030605
thromboplastin	I:C0030605
time	I:C0030605
(	O
STA	O
-	O
R	O
Evolution	O
Stago	O
)	O
,	O
and	O
using	O
Rotem	O
thrombelastometry	I:C0040017
,	O
and	O
platelet	O
aggregation	I:C0032176
using	O
a	O
Chrono	O
-	O
Log	O
700	O
aggregometer	O
.	O

Blood	O
samples	I:C0178913
were	O
collected	O
before	O
and	O
after	O
apheresis	O
to	O
assess	O
changes	O
in	O
oxygen	O
metabolism	I:C3156653
and	O
coagulation	B:C0005778
by	O
prothrombin	O
time	I:C0033707
,	O
activated	O
partial	I:C0030605
thromboplastin	I:C0030605
time	I:C0030605
(	O
STA	O
-	O
R	O
Evolution	O
Stago	O
)	O
,	O
and	O
using	O
Rotem	O
thrombelastometry	I:C0040017
,	O
and	O
platelet	O
aggregation	I:C0032176
using	O
a	O
Chrono	O
-	O
Log	O
700	O
aggregometer	O
.	O

Blood	O
samples	I:C0178913
were	O
collected	O
before	O
and	O
after	O
apheresis	O
to	O
assess	O
changes	O
in	O
oxygen	O
metabolism	I:C3156653
and	O
coagulation	O
by	O
prothrombin	B:C0033707
time	I:C0033707
,	O
activated	O
partial	I:C0030605
thromboplastin	I:C0030605
time	I:C0030605
(	O
STA	O
-	O
R	O
Evolution	O
Stago	O
)	O
,	O
and	O
using	O
Rotem	O
thrombelastometry	I:C0040017
,	O
and	O
platelet	O
aggregation	I:C0032176
using	O
a	O
Chrono	O
-	O
Log	O
700	O
aggregometer	O
.	O

Blood	O
samples	I:C0178913
were	O
collected	O
before	O
and	O
after	O
apheresis	O
to	O
assess	O
changes	O
in	O
oxygen	O
metabolism	I:C3156653
and	O
coagulation	O
by	O
prothrombin	O
time	I:C0033707
,	O
activated	B:C0030605
partial	I:C0030605
thromboplastin	I:C0030605
time	I:C0030605
(	O
STA	O
-	O
R	O
Evolution	O
Stago	O
)	O
,	O
and	O
using	O
Rotem	O
thrombelastometry	I:C0040017
,	O
and	O
platelet	O
aggregation	I:C0032176
using	O
a	O
Chrono	O
-	O
Log	O
700	O
aggregometer	O
.	O

Blood	O
samples	I:C0178913
were	O
collected	O
before	O
and	O
after	O
apheresis	O
to	O
assess	O
changes	O
in	O
oxygen	O
metabolism	I:C3156653
and	O
coagulation	O
by	O
prothrombin	O
time	I:C0033707
,	O
activated	O
partial	I:C0030605
thromboplastin	I:C0030605
time	I:C0030605
(	O
STA	O
-	O
R	O
Evolution	O
Stago	O
)	O
,	O
and	O
using	O
Rotem	B:C0040017
thrombelastometry	I:C0040017
,	O
and	O
platelet	O
aggregation	I:C0032176
using	O
a	O
Chrono	O
-	O
Log	O
700	O
aggregometer	O
.	O

Blood	O
samples	I:C0178913
were	O
collected	O
before	O
and	O
after	O
apheresis	O
to	O
assess	O
changes	O
in	O
oxygen	O
metabolism	I:C3156653
and	O
coagulation	O
by	O
prothrombin	O
time	I:C0033707
,	O
activated	O
partial	I:C0030605
thromboplastin	I:C0030605
time	I:C0030605
(	O
STA	O
-	O
R	O
Evolution	O
Stago	O
)	O
,	O
and	O
using	O
Rotem	O
thrombelastometry	I:C0040017
,	O
and	O
platelet	B:C0032176
aggregation	I:C0032176
using	O
a	O
Chrono	O
-	O
Log	O
700	O
aggregometer	O
.	O

During	O
each	O
cycle	O
of	O
the	O
apheresis	B:C0005791
,	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
(	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
)	O
was	O
decreased	O
and	O
heart	O
rate	I:C0018810
was	O
increased	O
by	O
blood	O
withdrawal	O
,	O
but	O
both	O
recovered	O
after	O
blood	O
return	O
.	O

During	O
each	O
cycle	O
of	O
the	O
apheresis	O
,	O
mean	B:C0428886
arterial	I:C0428886
pressure	I:C0428886
(	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
)	O
was	O
decreased	O
and	O
heart	O
rate	I:C0018810
was	O
increased	O
by	O
blood	O
withdrawal	O
,	O
but	O
both	O
recovered	O
after	O
blood	O
return	O
.	O

During	O
each	O
cycle	O
of	O
the	O
apheresis	O
,	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
(	O
mean	B:C0428886
arterial	I:C0428886
pressure	I:C0428886
)	O
was	O
decreased	O
and	O
heart	O
rate	I:C0018810
was	O
increased	O
by	O
blood	O
withdrawal	O
,	O
but	O
both	O
recovered	O
after	O
blood	O
return	O
.	O

During	O
each	O
cycle	O
of	O
the	O
apheresis	O
,	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
(	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
)	O
was	O
decreased	O
and	O
heart	B:C0018810
rate	I:C0018810
was	O
increased	O
by	O
blood	O
withdrawal	O
,	O
but	O
both	O
recovered	O
after	O
blood	O
return	O
.	O

During	O
each	O
cycle	O
of	O
the	O
apheresis	O
,	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
(	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
)	O
was	O
decreased	O
and	O
heart	O
rate	I:C0018810
was	O
increased	O
by	O
blood	B:C0005767
withdrawal	O
,	O
but	O
both	O
recovered	O
after	O
blood	O
return	O
.	O

During	O
each	O
cycle	O
of	O
the	O
apheresis	O
,	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
(	O
mean	O
arterial	I:C0428886
pressure	I:C0428886
)	O
was	O
decreased	O
and	O
heart	O
rate	I:C0018810
was	O
increased	O
by	O
blood	O
withdrawal	O
,	O
but	O
both	O
recovered	O
after	O
blood	B:C0005767
return	O
.	O

On	O
the	O
completion	O
of	O
the	O
apheresis	B:C0005791
,	O
platelet	O
count	I:C0392386
decreased	I:C0392386
from	O
baseline	O
345	O
±	O
15	O
10	O
(	O
9	O
)	O
/	O
L	O
to	O
141	O
±	O
14	O
10	O
(	O
9	O
)	O
/	O
L	O
and	O
fibrinogen	O
levels	I:C1318051
were	O
reduced	O
from	O
124	O
±	O
5	O
to	O
99	O
±	O
4	O
mg/dL	O
(	O
both	O
p	O
<	O
0.05	O
)	O
.	O

On	O
the	O
completion	O
of	O
the	O
apheresis	O
,	O
platelet	B:C0392386
count	I:C0392386
decreased	I:C0392386
from	O
baseline	O
345	O
±	O
15	O
10	O
(	O
9	O
)	O
/	O
L	O
to	O
141	O
±	O
14	O
10	O
(	O
9	O
)	O
/	O
L	O
and	O
fibrinogen	O
levels	I:C1318051
were	O
reduced	O
from	O
124	O
±	O
5	O
to	O
99	O
±	O
4	O
mg/dL	O
(	O
both	O
p	O
<	O
0.05	O
)	O
.	O

On	O
the	O
completion	O
of	O
the	O
apheresis	O
,	O
platelet	O
count	I:C0392386
decreased	I:C0392386
from	O
baseline	O
345	O
±	O
15	O
10	O
(	O
9	O
)	O
/	O
L	O
to	O
141	O
±	O
14	O
10	O
(	O
9	O
)	O
/	O
L	O
and	O
fibrinogen	B:C1318051
levels	I:C1318051
were	O
reduced	O
from	O
124	O
±	O
5	O
to	O
99	O
±	O
4	O
mg/dL	O
(	O
both	O
p	O
<	O
0.05	O
)	O
.	O

Although	O
oxygen	B:C0429622
delivery	I:C0429622
remained	O
unchanged	O
,	O
oxygen	O
consumption	I:C0030055
was	O
decreased	O
from	O
4.0	O
±	O
0.2	O
to	O
3.2	O
±	O
0.0	O
mL	O
O2/kg/min	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Although	O
oxygen	O
delivery	I:C0429622
remained	O
unchanged	B:C0442739
,	O
oxygen	O
consumption	I:C0030055
was	O
decreased	O
from	O
4.0	O
±	O
0.2	O
to	O
3.2	O
±	O
0.0	O
mL	O
O2/kg/min	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Although	O
oxygen	O
delivery	I:C0429622
remained	O
unchanged	O
,	O
oxygen	B:C0030055
consumption	I:C0030055
was	O
decreased	O
from	O
4.0	O
±	O
0.2	O
to	O
3.2	O
±	O
0.0	O
mL	O
O2/kg/min	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Rotem	B:C2585389
alpha	I:C2585389
(	O
clotting	O
speed	I:C2266672
)	O
decreased	O
from	O
79	O
±	O
0	O
to	O
69	O
±	O
1°	O
and	O
maximum	O
clot	O
firmness	O
(	O
MCF	O
or	O
clot	O
strength	O
)	O
decreased	O
from	O
71	O
±	O
1	O
to	O
57	O
±	O
1	O
mm	O
(	O
both	O
p	O
<	O
0.05	O
)	O
.	O

Rotem	O
alpha	I:C2585389
(	O
clotting	B:C2266672
speed	I:C2266672
)	O
decreased	O
from	O
79	O
±	O
0	O
to	O
69	O
±	O
1°	O
and	O
maximum	O
clot	O
firmness	O
(	O
MCF	O
or	O
clot	O
strength	O
)	O
decreased	O
from	O
71	O
±	O
1	O
to	O
57	O
±	O
1	O
mm	O
(	O
both	O
p	O
<	O
0.05	O
)	O
.	O

No	B:C0442739
changes	I:C0442739
were	O
observed	O
in	O
prothrombin	O
time	I:C1533047
or	O
activated	O
partial	I:C1318441
thromboplastin	I:C1318441
time	I:C1318441
.	O

No	O
changes	I:C0442739
were	O
observed	O
in	O
prothrombin	B:C1533047
time	I:C1533047
or	O
activated	O
partial	I:C1318441
thromboplastin	I:C1318441
time	I:C1318441
.	O

No	O
changes	I:C0442739
were	O
observed	O
in	O
prothrombin	O
time	I:C1533047
or	O
activated	B:C1318441
partial	I:C1318441
thromboplastin	I:C1318441
time	I:C1318441
.	O

Platelet	B:C0032176
aggregation	I:C0032176
induced	O
by	O
arachidonic	O
acid	I:C0003695
or	O
collagen	O
was	O
decreased	O
to	O
28	O
±	O
6	O
%	O
or	O
71	O
±	O
3	O
%	O
of	O
baseline	O
values	O
(	O
p	O
<	O
0.05	O
)	O
,	O
respectively	O
.	O

Platelet	O
aggregation	I:C0032176
induced	O
by	O
arachidonic	B:C0003695
acid	I:C0003695
or	O
collagen	O
was	O
decreased	O
to	O
28	O
±	O
6	O
%	O
or	O
71	O
±	O
3	O
%	O
of	O
baseline	O
values	O
(	O
p	O
<	O
0.05	O
)	O
,	O
respectively	O
.	O

Platelet	O
aggregation	I:C0032176
induced	O
by	O
arachidonic	O
acid	I:C0003695
or	O
collagen	B:C0009325
was	O
decreased	O
to	O
28	O
±	O
6	O
%	O
or	O
71	O
±	O
3	O
%	O
of	O
baseline	O
values	O
(	O
p	O
<	O
0.05	O
)	O
,	O
respectively	O
.	O

Platelet	B:C0032202
apheresis	I:C0032202
caused	O
significant	O
fluctuations	O
in	O
hemodynamics	O
,	O
reduced	O
oxygen	I:C1167679
consumption	I:C1167679
,	O
in	O
addition	O
to	O
the	O
compromised	O
platelet	O
aggregation	I:C0032176
and	O
clotting	O
function	I:C1328723
expected	O
.	O

Platelet	O
apheresis	I:C0032202
caused	O
significant	O
fluctuations	O
in	O
hemodynamics	B:C0019010
,	O
reduced	O
oxygen	I:C1167679
consumption	I:C1167679
,	O
in	O
addition	O
to	O
the	O
compromised	O
platelet	O
aggregation	I:C0032176
and	O
clotting	O
function	I:C1328723
expected	O
.	O

Platelet	O
apheresis	I:C0032202
caused	O
significant	O
fluctuations	O
in	O
hemodynamics	O
,	O
reduced	B:C1167679
oxygen	I:C1167679
consumption	I:C1167679
,	O
in	O
addition	O
to	O
the	O
compromised	O
platelet	O
aggregation	I:C0032176
and	O
clotting	O
function	I:C1328723
expected	O
.	O

Platelet	O
apheresis	I:C0032202
caused	O
significant	O
fluctuations	O
in	O
hemodynamics	O
,	O
reduced	O
oxygen	I:C1167679
consumption	I:C1167679
,	O
in	O
addition	O
to	O
the	O
compromised	O
platelet	B:C0032176
aggregation	I:C0032176
and	O
clotting	O
function	I:C1328723
expected	O
.	O

Platelet	O
apheresis	I:C0032202
caused	O
significant	O
fluctuations	O
in	O
hemodynamics	O
,	O
reduced	O
oxygen	I:C1167679
consumption	I:C1167679
,	O
in	O
addition	O
to	O
the	O
compromised	O
platelet	O
aggregation	I:C0032176
and	O
clotting	B:C1328723
function	I:C1328723
expected	O
.	O

The	O
observations	B:C0302523
warrant	O
consideration	O
in	O
humans	O
undergoing	O
apheresis	O
over	O
extended	O
periods	O
.	O

The	O
observations	O
warrant	O
consideration	O
in	O
humans	B:C0086418
undergoing	O
apheresis	O
over	O
extended	O
periods	O
.	O

The	O
observations	O
warrant	O
consideration	O
in	O
humans	O
undergoing	O
apheresis	B:C0005791
over	O
extended	O
periods	O
.	O

